HIV vs HCV: Agree with your assessment completely. I think HCV market size is over estimated right now. Most patients in under-developed/developing countries won't be treated with these expensive new oral drugs, and there will be no big foundations like in HIV that will provide billions of funding for the treatment in under-developed/developing countries.
Market Data 
Markets 
AI
